Fontan CirculationNCT06258382
Fontan Circulation and Reproductive Health in a National Swedish Cohort
An observational study of Fontan Circulation, run by Caroline Lilliecreutz at 15 sites in Sweden.
Trial summary
In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section. Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Fontan Circulation
- What is being tested?
- Questionnaires and functional test
- How many people
- 600 participants
- Where
- 15 sitesSweden
- Study dates
- 1 Nov 2023to 1 Oct 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Approximately 200 patients with fontan circulation and their potential partners. Age and gender matched control groups.
Who may be able to join
- Fontan circulation,
- Age ≥18 years at inclusion,
- Follow-up at specialist clinics,
- Ability to fill in questionnaires in the Swedish language (no other alternative available) or
- Partner of a person with Fontan circulation,
- Age ≥18 years at inclusion
- Ability to fill in questionnaires in the Swedish language (no other alternative available).
- or •Age- and gender-matched individuals are recruited via the population registry. They must not have congenital heart disease.
Who cannot join
- -
Trial locations and contacts
15 sites in 1 country.
15 sites in 1 country
Sweden15 sites, 15 recruiting
- Not yet recruiting
Sahlgrenska Academy, University of Gothenburg Sahlgrenska University Hospital
Gothenburg
Eva Furenäs, MD PhD, eva.furenas@vgregion.se,
- Not yet recruiting
Sahlgrenska University Hospital,
Gothenburg
Mårten Alkmark, MD PhD, marten.alkmark@vgregion.se
- Not yet recruiting
University Hospital, Linköping
Linköping
Alexsandra Trzebiatowska, MD, PhD,, Aleksandra.Trzebiatowska-Krzynska@regionostergotland.se,
- Not yet recruiting
Linköping University, University Hospital
Linköping, Östergötland County, 58158 Linköping
Caroline Lilliecreutz, PhD Associate professor, +46708731124, caroline.lilliecreutz@regionostergotland.se
- Recruiting
Lund University Skåne University Hospital
Lund, Skåne County
Joanna Hlebowicz, Docent PhD, joanna.hlebowicz@med.lu.se
- Not yet recruiting
Skåne University Hospital, Lund University
Lund
Emma von Wowern, MD PhD, emma.von_wowern@med.lu.se
- Not yet recruiting
Karolinska University Hospital
Stockholm
Eva Mattsson, Chief Physician, eva.mattsson@regionstockholm.se,
- Not yet recruiting
Karolinska University Hospital
Stockholm
Edit Nagy, MD, PhD, edit.nagy@regionstockholm.se
- Not yet recruiting
Karolinska University Hospital
Stockholm
Maria Sennström, MD PhD, maria.sennstrom@ki.se
- Not yet recruiting
University West, Drottning Silvia's Children's Hospital/Sahlgrenska University Hospital,
Trollhättan
Malin Berghammer, Professor, malin.berghammer@hv.se
- Not yet recruiting
Umeå University, Norrland University Hospital
Umeå
Bengt Johansson, Professor, bengt.johansson@umu.se
- Not yet recruiting
Umeå University, Norrlands University Hospital
Umeå
Ulrika Ottander, chief physician, ulrika.ottander@umu.se
- Not yet recruiting
Umeå University, Norrlands University Hospital
Umeå
Annika Bay, senior lecturer, Annika.bay@umu.se
- Recruiting
Akademiska Hospital Uppsala.Uppsala University.
Uppsala
Anna-Karin Wikström, Professor, Anna-karin.wikstrom@kbh.uu.se
- Recruiting
Uppsala University, Akademiska Hospital
Uppsala
Christina Christersson, Associate Professor
christina.christersson@medsci.uu.se
About this study
In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section.
Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common.
Read more
The impact of Fontan circulation on reproductive health and fertility needs to be illuminated, and additional studies are required from both medical and psychosocial perspectives.Cognitive impairment is common among patients with congenital heart defects but is likely an overlooked cause of long-term illness.
Objective To study a large national population (n=200) of adults with Fontan circulation and their potential partners regarding.
- the prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (Study A).
- the outcomes of pregnancy, choice of delivery mode, and complications in patients with Fontan circulation (Study B).
- the experiences and perceptions of becoming parents among women (n=20) and men (n=20), as well as elucidate reasoning and family planning among women and men (n=20) who have not become parents (Study C).
- Investigate the prevalence and explanatory factors for (Sub-study D):
- Fatigue
- In-depth cognitive screening to describe specific cognitive functions such as auditory memory, visuospatial memory, attention, cognitive speed, and executive functions.
The aim of this research is to gain more knowledge in an area that has been relatively underexplored, thus improving care for women and men with congenital heart defects.
Read the detailed description
Every year, approximately 2000 children are born with congenital heart defects in Sweden. In a small percentage of these cases, the heart defects are so severe that they cannot be corrected to resemble or function like a healthy heart. Instead, these highly complex heart defects are operated on to establish "single-ventricle circulation," also known as Fontan circulation or TCPC circulation (total cavopulmonary connection). This means there is only one chamber in circulation, pumping blood into the body's main artery. To facilitate venous blood flow to the lungs for oxygenation and back to the heart chamber, high venous pressure and low resistance in the lung circulation are required.
This type of blood circulation can lead to severe complications later in life, including heart failure, low oxygen saturation, blood clot formation, liver cirrhosis, bleeding, protein-losing enteropathy, arrhythmias, and reduced physical capacity. In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section.
Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common. The severity of different heart defects varies and has varying degrees of impact on patients' daily lives. Pregnancy and childbirth exert significant stress on a woman and her body. Due to the increased metabolic needs of the fetus and the mother, hemodynamics change during a normal pregnancy, with approximately a 40-50% increase in cardiac output and plasma volume. Pregnancy is often well tolerated by women with congenital heart defects, but there might be an increased risk of complications associated with pregnancy and childbirth. Women with complex congenital heart defects have a higher risk of experiencing cardiovascular events during pregnancy compared to women with simpler congenital heart defects. There is also a greater risk of infertility for these women. The modified WHO classifications system (mWHO class I-IV) can be used to assess risk associated with pregnancy and childbirth for women with heart disease, where higher class is associated with increased morbidity and mortality. In Fontan circulation, the risk of complications during pregnancy is considered high if the woman is classified as mWHO III or IV. If a woman experiences complications due to Fontan circulation before pregnancy, she is classified as mWHO IV and will be discouraged from pregnancy due to a very high risk for both maternal and fetal complications. During pregnancy, there is an increased risk of arrhythmias, heart failure symptoms, and thrombosis. Miscarriage risk is high for women with Fontan circulation, and preterm delivery is common, often resulting in low birth weight for gestational age. There is also an increased risk of peripartum bleeding. It is recommended that patients with Fontan circulation have frequent check-ups during pregnancy and in the first weeks after delivery.
Some women with complex congenital heart defects choose not to undergo pregnancy due to their heart condition. Others choose to become pregnant despite being informed about the high risks and advice against pregnancy, which places high demands on the care and follow-up of these patients. How men with Fontan circulation perceive their parental abilities and the possibility of having children is poorly studied, as well as how a partner of a person with complex congenital heart defects thinks and reasons about parenthood.
The impact of Fontan circulation on reproductive health and fertility needs to be illuminated, and additional studies are required from both medical and psychosocial perspectives.
Cognitive impairment is common among patients with congenital heart defects but is likely an overlooked cause of long-term illness. Cognitive function and fatigue significantly affect all aspects of quality of life, including employment opportunities, educational level, and the ability to maintain meaningful social relationships, such as marriage. How this affects reproductive health is not fully understood.
Objective:
To study a large national population (n=200) of adults with Fontan circulation and their potential partners regarding.
- the prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (Study A).
- the outcomes of pregnancy, choice of delivery mode, and complications in patients with Fontan circulation (Study B).
- the experiences and perceptions of becoming parents among women (n=20) and men (n=20), as well as elucidate reasoning and family planning among women and men (n=20) who have not become parents (Study C).
- Investigate the prevalence and explanatory factors for (Sub-study D):
- Fatigue
- In-depth cognitive screening to describe specific cognitive functions such as auditory memory, visuospatial memory, attention, cognitive speed, and executive functions.
Work Plan The study is a national study involving six national centers: Gothenburg, Linköping, Lund, Stockholm, Umeå and Uppsala. Each participating center includes all patients with Fontan circulation. This involves approximately 200 patients and their potential partners.
In Sweden, there are an estimated 40,000 adults with congenital heart defects. We have a unique national register for congenital heart defects, The Swedish Registry of Congenital Heart Disease (SWEDCON), which started in the 1990s with Grown Up Congenital Heart disease (GUCH) and expanded in 2009 to include pediatric cardiology, heart interventions, and now fetal cardiology in congenital heart defects.
Design: Observational study.
The aim of this research is to gain more knowledge in an area that has been relatively underexplored, thus improving care for women and men with congenital heart defects. It is relatively common for women with congenital heart defects to avoid pregnancy due to their heart condition. In cases of aortic valve and/or pulmonary valve disease, Tetralogy of Fallot, and transposition of the great arteries, up to a third of women reported they did not want to have children because of their heart condition .
Therefore, there is significant patient benefit in conducting research among women and men with congenital heart defects. By gaining more knowledge in a new and relatively unexplored area, care can be improved, enabling these women to give birth if they wish without having to avoid it due to their chronic disabilities. Women with less complex heart disease and better functional status can also benefit from new knowledge and improved care, especially since there is a link between maternal congenital heart defects and lower birth weight in infants.
- Conditions
- Fontan Circulation
- Being tested
- Questionnaires and functional test
- Keywords
- reproductive health, cognitive impairment, grown up heart disease
- Medical subject headings
- Cognitive Dysfunction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Questionnaires and functional testOther
Data will be collected from different sources. Questinnaires, Medical journal, Obstetrical records and functional tests
| Study group | Role | What they receive |
|---|---|---|
| Male with Fontan circulation | Different data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- Receives: Other: Questionnaires and functional test | |
| Female with Fontan circulation | Different data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- Receives: Other: Questionnaires and functional test | |
| Partner to male with Fontan circulation | Different data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- Receives: Other: Questionnaires and functional test | |
| Partner to female with Fontan circulation | Different data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- Receives: Other: Questionnaires and functional test | |
| Male control group | Different data will be collected along with several questionnaires concerning reproductive health . Approximate 100 individuals will be included Receives: Other: Questionnaires and functional test | |
| Female control group | Different data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included Receives: Other: Questionnaires and functional test |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation
Reproductive health questionnaire for Woman/reproductive health questionnaire for Man, and a questionnaire for the potential partner, designed for this study.
International Index of Erectile Function (IIEF5) Female Sexual Function Index (FSFI) EQ-5D is an instrument to describe and measure health and health-related quality of life.
Measured: 3 hours
Secondary outcomes (3)
Obstetric, neonatal and cardiological variables before, during, and after pregnancy
Cardiological complications during pregnancy, at delivery, first 6 months Pregnancy,Obstetric and Neonatal complications e.g.Gestational diabetes, Pregnancy-induced hypertension, Preeclampsia, Anemia,Thromboembolic event, hepatosis, Chorioamnionitis-other Relevant medication. Gestational week at partus Premature delivery Induction with indication, Delivery method; uncomplicated vaginal delivery, instrumental vaginal delivery, Cesarean section,Bleeding (ml) at partus, Birth trauma Placental retention, Maternal death.
Admission to neonatal ward, Neonatal complications, Child malformations- Type-, Neonatal death, Birth weight, small for gestational age (SGA), large for gestational age (LGA), average for gestational age (AGA) Apgar
Measured: 4 hours
Experiences and perceptions of parenthood
Thoughts, fears, and hopes,Information and knowledge before and during pregnancy, Follow-ups during pregnancy and their extent, Need for special contact at the clinic for congenital heart defects during pregnancy, Physical and mental well-being during and after childbirth ,Describe experiences and perceptions of parenthood in men Long-term follow-up; additional pregnancy, intervention, hospitalization for heart failure/arrhythmia/FALD/endocarditis/infection/stroke, transplantation, cardiovascular death, non-cardiovascular death after 2.5, 10, and 15 years .
Control group: As control subjects, 200 age- and gender-matched individuals are recruited via the population registry. They must not have congenital heart disease. They will complete the same questionnaires as the study participants and will be asked questions about health status.
Measured: 4 hours
Cognitive function
Multidimensional Fatigue Inventory (MFI-20) Montreal Cognitive Assessment (MoCA) SDMT - Symbol Digit Modalities Test. . TMT A and B - Trail Making Test. BVMT-R - Brief Visuospatial Memory Test. CWIT - Color Word Interference Test. M. FAS - Verbal Fluency Test. DEX - Dysexecutive Questionnaire. . HADs- Hospital Anxiety and Depression Scale BDI II- Beck Depression Inventory
Measured: 4 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Feb 2024
- Study start1 Nov 2023
- Primary completion1 Oct 2025 (estimated)
- Study completion1 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Fontan CirculationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Caroline Lilliecreutz
- Sponsor type
- Other government
- Collaborators
- Uppsala University, Umeå University, Lund University, Göteborg University, Karolinska Institutet
- Responsible party
- Sponsor-investigator, Caroline Lilliecreutz, Linkoeping University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06258382
- Sponsor's protocol ID
- 2023-02526-01
- Other IDs
- 2023
- Status last verified
- Oct 2024
- First submitted
- 6 Feb 2024
- Last updated
- 16 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Fontan Circulation and Reproductive Health in a National Swedish Cohort
- ClinicalTrials.gov ID
- NCT06258382
- Acronym / sponsor ID
- 2023-02526-01
- Conditions
- Fontan Circulation
- Keywords
- reproductive health, cognitive impairment, grown up heart disease
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- Caroline LilliecreutzOther government
- Collaborators
- Uppsala University, Umeå University, Lund University, Göteborg University, Karolinska Institutet
- Study start
- 1 Nov 2023 (actual)
- Primary completion
- 1 Oct 2025 (estimated)
- Study completion
- 1 Oct 2026 (estimated)
- First posted
- 14 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section.
Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common.
The impact of Fontan circulation on reproductive health and fertility needs to be illuminated, and additional studies are required from both medical and psychosocial perspectives.Cognitive impairment is common among patients with congenital heart defects but is likely an overlooked cause of long-term illness.
Objective To study a large national population (n=200) of adults with Fontan circulation and their potential partners regarding.
- the prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (Study A).
- the outcomes of pregnancy, choice of delivery mode, and complications in patients with Fontan circulation (Study B).
- the experiences and perceptions of becoming parents among women (n=20) and men (n=20), as well as elucidate reasoning and family planning among women and men (n=20) who have not become parents (Study C).
- Investigate the prevalence and explanatory factors for (Sub-study D):
- Fatigue
- In-depth cognitive screening to describe specific cognitive functions such as auditory memory, visuospatial memory, attention, cognitive speed, and executive functions.
The aim of this research is to gain more knowledge in an area that has been relatively underexplored, thus improving care for women and men with congenital heart defects.
Detailed description
Every year, approximately 2000 children are born with congenital heart defects in Sweden. In a small percentage of these cases, the heart defects are so severe that they cannot be corrected to resemble or function like a healthy heart. Instead, these highly complex heart defects are operated on to establish "single-ventricle circulation," also known as Fontan circulation or TCPC circulation (total cavopulmonary connection). This means there is only one chamber in circulation, pumping blood into the body's main artery. To facilitate venous blood flow to the lungs for oxygenation and back to the heart chamber, high venous pressure and low resistance in the lung circulation are required.
This type of blood circulation can lead to severe complications later in life, including heart failure, low oxygen saturation, blood clot formation, liver cirrhosis, bleeding, protein-losing enteropathy, arrhythmias, and reduced physical capacity. In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section.
Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common. The severity of different heart defects varies and has varying degrees of impact on patients' daily lives. Pregnancy and childbirth exert significant stress on a woman and her body. Due to the increased metabolic needs of the fetus and the mother, hemodynamics change during a normal pregnancy, with approximately a 40-50% increase in cardiac output and plasma volume. Pregnancy is often well tolerated by women with congenital heart defects, but there might be an increased risk of complications associated with pregnancy and childbirth. Women with complex congenital heart defects have a higher risk of experiencing cardiovascular events during pregnancy compared to women with simpler congenital heart defects. There is also a greater risk of infertility for these women. The modified WHO classifications system (mWHO class I-IV) can be used to assess risk associated with pregnancy and childbirth for women with heart disease, where higher class is associated with increased morbidity and mortality. In Fontan circulation, the risk of complications during pregnancy is considered high if the woman is classified as mWHO III or IV. If a woman experiences complications due to Fontan circulation before pregnancy, she is classified as mWHO IV and will be discouraged from pregnancy due to a very high risk for both maternal and fetal complications. During pregnancy, there is an increased risk of arrhythmias, heart failure symptoms, and thrombosis. Miscarriage risk is high for women with Fontan circulation, and preterm delivery is common, often resulting in low birth weight for gestational age. There is also an increased risk of peripartum bleeding. It is recommended that patients with Fontan circulation have frequent check-ups during pregnancy and in the first weeks after delivery.
Some women with complex congenital heart defects choose not to undergo pregnancy due to their heart condition. Others choose to become pregnant despite being informed about the high risks and advice against pregnancy, which places high demands on the care and follow-up of these patients. How men with Fontan circulation perceive their parental abilities and the possibility of having children is poorly studied, as well as how a partner of a person with complex congenital heart defects thinks and reasons about parenthood.
The impact of Fontan circulation on reproductive health and fertility needs to be illuminated, and additional studies are required from both medical and psychosocial perspectives.
Cognitive impairment is common among patients with congenital heart defects but is likely an overlooked cause of long-term illness. Cognitive function and fatigue significantly affect all aspects of quality of life, including employment opportunities, educational level, and the ability to maintain meaningful social relationships, such as marriage. How this affects reproductive health is not fully understood.
Objective:
To study a large national population (n=200) of adults with Fontan circulation and their potential partners regarding.
- the prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (Study A).
- the outcomes of pregnancy, choice of delivery mode, and complications in patients with Fontan circulation (Study B).
- the experiences and perceptions of becoming parents among women (n=20) and men (n=20), as well as elucidate reasoning and family planning among women and men (n=20) who have not become parents (Study C).
- Investigate the prevalence and explanatory factors for (Sub-study D):
- Fatigue
- In-depth cognitive screening to describe specific cognitive functions such as auditory memory, visuospatial memory, attention, cognitive speed, and executive functions.
Work Plan The study is a national study involving six national centers: Gothenburg, Linköping, Lund, Stockholm, Umeå and Uppsala. Each participating center includes all patients with Fontan circulation. This involves approximately 200 patients and their potential partners.
In Sweden, there are an estimated 40,000 adults with congenital heart defects. We have a unique national register for congenital heart defects, The Swedish Registry of Congenital Heart Disease (SWEDCON), which started in the 1990s with Grown Up Congenital Heart disease (GUCH) and expanded in 2009 to include pediatric cardiology, heart interventions, and now fetal cardiology in congenital heart defects.
Design: Observational study.
The aim of this research is to gain more knowledge in an area that has been relatively underexplored, thus improving care for women and men with congenital heart defects. It is relatively common for women with congenital heart defects to avoid pregnancy due to their heart condition. In cases of aortic valve and/or pulmonary valve disease, Tetralogy of Fallot, and transposition of the great arteries, up to a third of women reported they did not want to have children because of their heart condition .
Therefore, there is significant patient benefit in conducting research among women and men with congenital heart defects. By gaining more knowledge in a new and relatively unexplored area, care can be improved, enabling these women to give birth if they wish without having to avoid it due to their chronic disabilities. Women with less complex heart disease and better functional status can also benefit from new knowledge and improved care, especially since there is a link between maternal congenital heart defects and lower birth weight in infants.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Male with Fontan circulation | – | Other: Questionnaires and functional testDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- |
| Female with Fontan circulation | – | Other: Questionnaires and functional testDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- |
| Partner to male with Fontan circulation | – | Other: Questionnaires and functional testDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- |
| Partner to female with Fontan circulation | – | Other: Questionnaires and functional testDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included- |
| Male control group | – | Other: Questionnaires and functional testDifferent data will be collected along with several questionnaires concerning reproductive health . Approximate 100 individuals will be included |
| Female control group | – | Other: Questionnaires and functional testDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Approximately 200 patients with fontan circulation and their potential partners. Age and gender matched control groups.
Key inclusion criteria (8 listed)
- Fontan circulation,
- Age ≥18 years at inclusion,
- Follow-up at specialist clinics,
- Ability to fill in questionnaires in the Swedish language (no other alternative available) or
- Partner of a person with Fontan circulation,
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Questionnaires and functional testData will be collected from different sources. Questinnaires, Medical journal, Obstetrical records and functional tests | Other | Female control group, Female with Fontan circulation, Male control group, Male with Fontan circulation, Partner to female with Fontan circulation, Partner to male with Fontan circulation |
Primary outcome
Prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation
Time frame: 3 hours
Reproductive health questionnaire for Woman/reproductive health questionnaire for Man, and a questionnaire for the potential partner, designed for this study. International Index of Erectile Function (IIEF5) Female Sexual Function Index (FSFI) EQ-5D is an instrument to describe and measure health and health-related quality of life.
3 secondary outcomes
Obstetric, neonatal and cardiological variables before, during, and after pregnancy
Time frame: 4 hours
Experiences and perceptions of parenthood
Time frame: 4 hours
Cognitive function
Time frame: 4 hours
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Fontan Circulation
RecruitingPhase 1
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
Fontan Circulation
Not yet recruitingObservational study
A Simple Method for Monitoring the End-organ Function in Patients With Fontan Circulation.
Fontan Procedure, Fontan Circulation
RecruitingPhase 3
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
Congenital Heart Disease
Enrolling by invitation
Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease
Pulmonary Hypertension, Right Ventricular Outflow Tract Dysfunction
Recruiting
Venous Compression in Fontan
Single-ventricle, Fontan Circulation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
15 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Fontan Circulation, run by Caroline Lilliecreutz at 15 sites in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 15 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Caroline Lilliecreutz, PhD, Docent (+46708731124, caroline.lilliecreutz@regionostergotland.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (time frame: 3 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2024.